450 participants from 20 countries and 200 companies have signed up for the ECCP-event September 14 – 16. Business people, investors and researchers from European academic and clinical research centers, tech transfer offices, and SMEs have sent more than 1200 meeting requests and 600 meetings are set up.

“There seems to be a high level of activity,” says Oslo Cancer Cluster chairman Jonas Einarsson. “Our companies are reporting that they are meeting many larger players, including global pharmaceutical firms, that they would not normally meet at other conferences.”

From Oslo Cancer Cluster, eleven companies and institutions are participating. Among them, Affitech, BerGen Bio and PCI Biotech will be presenting. Several of the highly skilled clinicians and cancer researchers from Oslo University Hospital are joining the conference and are to meet the Toulouse Hospital during the conference to further extend the collaboration between the two clusters. Also the the Norwegian Cancer Society is in Toulouse to meet their French counterparts.

ECCP2011 is this year arranged in cooperation with American MaryLand Biotechnology Centre and the Danish-Swedish cooperation Medicon Valley Alliance. The world’s most renowned cancer hospital MD Anderson from Houston, USA has also taken the trip over the Atlantic to meet with representatives from Oslo University Hospital, Radium.

Read more at www.oslocancercluster.no or www.ecc-partnering.com